Hong Kong experts back Pfizer-BioNTech's Covid-19 vaccine


Source: straitstimes.com straitstimes.com

Key Topics in this News Article:

News Snapshot:

HONG KONG (BLOOMBERG) - A panel of experts said they have recommended that Hong Kong approve the Pfizer-BioNTech coronavirus vaccine for use, clearing the way for a regulatory greenlight as the city tries to stamp out a winter outbreak that appears to be worsening. It is the first vaccine on track for approval in the Asian financial city, which likely means that the vulnerable groups which the government has prioritised such as healthcare workers and the elderly will receive this shot. The vaccine is being marketed by Shanghai Fosun Pharmaceutical Group in mainland China, Hong Kong, Macau and Taiwan. In...